The Current Status of High-Throughput Screening and Outlook for the Future, Part I

    loading  Checking for direct PDF access through Ovid

Abstract

This is Part 1 of a two-part article which assesses the emerging high-throughput screening (HTS) marketplace as it applies to drug discovery in the large-cap pharmaceutical companies.

The following topics are reviewed in Part 1: (1) historical overview and definitions employed in the HTS business, (2) segmentation of the markets as they evolve, (3) technology platforms, (4) competitive environment, and (5) an analyst’s view of the industry with respect to market opportunity, timelines and emerging trends.

In Part 2 of this article, which will appear in the May, 1998 issue of Drug & Market Development, a case study of a high-throughput screening company located in the San Francisco Bay area will be presented. This article will highlight the business models and target markets explored by the company, serving to illustrate the challenges and opportunities facing the emerging HTS industry.

Related Topics

    loading  Loading Related Articles